News

VBI Vaccines to Present at Jefferies 2017 Global Healthcare Conference

VBI Vaccines Inc. (VBIV)(VBV.TO) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that Jeff Baxter, VBI’s President and CEO, will present at the Jefferies 2017 Global Healthcare Conference on Friday, June 9, 2017 at 12:30 PM ET in New York City.

2017-06-20T11:58:56+00:00